Trials / Completed
CompletedNCT01230112
The Role of ITGAM in Systemic Lupus Erythematosus
TAP0307.6: Sub-study of TAP 0307- Enrollment of Normal Controls to Study the Role of ITGAM in Systemic Lupus Erythematosus
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (actual)
- Sponsor
- Northwell Health · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
Study to examine the role of ITGAM molecule in normal control subjects with known genetic variation in the ITGAM gene.
Conditions
Timeline
- Start date
- 2009-12-01
- Primary completion
- 2012-04-01
- Completion
- 2012-04-01
- First posted
- 2010-10-28
- Last updated
- 2013-07-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01230112. Inclusion in this directory is not an endorsement.